Biotoscana Investments S.A. (BOVESPA:GBIO33) have confirmed to the securities & exchange commission CVM negotiations engaged with prospective investors interested in acquiring its assets. Rumours says Eurofarma is in the race, but also Knight Therapeutics, MediPharm and others.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- BRL | -.--% | -.--% | -.--% |
- Stock Market
- Equities
- EUFA3 Stock
- News Eurofarma Laboratórios S.A.
- Biotoscana Confirms Divestiture Negotiations